Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X

Acta Biomaterialia

Volumn 19, Issue , 2015, Pages 166-179

  Lee, Karin L ^a   Shukla, Sourabh ^a   Wu, Mengzhi ^a   Ayat, Nadia R ^a   El Sanadi, Caroline E ^b   Wen, Amy M ^a   Edelbrock, John F ^c   Pokorski, Jonathan K ^c   Commandeur, Ulrich ^d   Dubyak, George R ^b   Steinmetz, Nicole F ^a,b,c  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Case Western Reserve University   (United States)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Biodistribution; Filamentous nanoparticle; PEGylation; Potato virus X; Stealth coating

Indexed keywords

ASPECT RATIO; BIOCOMPATIBILITY; BIODEGRADABILITY; BIODEGRADABLE POLYMERS; CONFORMATIONS; HISTOLOGY; MEDICAL IMAGING; MEDICAL NANOTECHNOLOGY; PHARMACOKINETICS; SURFACE CHEMISTRY; TUMORS; VIRUSES;

BIODISTRIBUTIONS; CHAIN CONFORMATIONS; FILAMENTOUS NANOPARTICLE; IN-VIVO; MONONUCLEAR PHAGOCYTE SYSTEMS; PEGYLATED; PEGYLATION; POTATO VIRUS; POTATO VIRUS X; STEALTH COATING;

NANOPARTICLES;

INTERLEUKIN 6; MACROGOL DERIVATIVE; NANOCARRIER; POLYETHYLENE GLYCOL FILAMENTOUS POTATO VIRUS X NANOPARTICLE; UNCLASSIFIED DRUG; NANOCAPSULE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; BIOAVAILABILITY; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL INTERACTION; CLEARANCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HISTOCOMPATIBILITY; HYDRODYNAMICS; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOLECULAR WEIGHT; MONONUCLEAR PHAGOCYTE; MOUSE; NANOMEDICINE; NONHUMAN; PHARMACOKINETICS; POTEXVIRUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CHEMISTRY; CONFORMATION; MATERIALS TESTING; PHYSIOLOGY; ULTRASTRUCTURE;

BASIDIOMYCOTA; POTATO VIRUS X;

MATERIALS TESTING; MOLECULAR CONFORMATION; MOLECULAR WEIGHT; NANOCAPSULES; POLYETHYLENE GLYCOLS; POTEXVIRUS;

EID: 84928427540     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.03.001     Document Type: Article

References (91)

1. S. Cai, K. Vijayan, D. Cheng, E.M. Lima, and D.E. Discher Micelles of different morphologies-advantages of worm-like filomicelles of PEO-PCL in paclitaxel delivery Pharm Res 24 2007 2099 2109
2. V.P. Chauhan, Z. Popovic, O. Chen, J. Cui, D. Fukumura, and M.G. Bawendi Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration Angew Chem Int Ed 50 2011 11417 11420
3. D.A. Christian, S. Cai, O.B. Garbuzenko, T. Harada, A.L. Zajac, and T. Minko Flexible filaments for in vivo imaging and delivery: Persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage Mol Pharm 6 2009 1343 1352
4. P. Decuzzi, B. Godin, T. Tanaka, S.Y. Lee, C. Chiappini, and X. Liu Size and shape effects in the biodistribution of intravascularly injected particles J Controlled Release 141 2010 320 327
5. Y. Geng, P. Dalhaimer, S. Cai, R. Tsai, M. Tewari, and T. Minko Shape effects of filaments versus spherical particles in flow and drug delivery Nat Nanotechnol 2 2007 249 255
6. F. Gentile, C. Chiappini, D. Fine, R.C. Bhavane, M.S. Peluccio, and M.M. Cheng The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows J Biomech 41 2008 2312 2318
7. S.Y. Lee, M. Ferrari, and P. Decuzzi Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows Nanotechnology 20 2009 495101
8. N. Doshi, B. Prabhakarpandian, A. Rea-Ramsey, K. Pant, S. Sundaram, and S. Mitragotri Flow and adhesion of drug carriers in blood vessels depend on their shape: A study using model synthetic microvascular networks J Controlled Release 146 2010 196 200
9. S.-Y. Lee, M. Ferrari, and P. Decuzzi Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows Nanotechnology 20 2009 495101
10. J. Tan, S. Shah, A. Thomas, H.D. Ou-Yang, and Y. Liu The influence of size, shape and vessel geometry on nanoparticle distribution Microfluid Nanofluid 14 2013 77 87
11. R. Vacha, F.J. Martinez-Veracoechea, and D. Frenkel Receptor-mediated endocytosis of nanoparticles of various shapes Nano Lett 11 2011 5391 5395
12. Arnida, M.M. Janát-Amsbury, A. Ray, C.M. Peterson, and H. Ghandehari Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages Eur J Pharm Biopharm 77 2011 417 423
13. C.P. Firme 3rd, and P.R. Bandaru Toxicity issues in the application of carbon nanotubes to biological systems Nanomed Nanotechnol Biol Med 6 2010 245 256
14. R. Chitale Merck hopes to extend gardasil vaccine to men J Natl Cancer Inst 101 2009 222 223
15. T.C. Liu, E. Galanis, and D. Kirn Clinical trial results with oncolytic virotherapy: A century of promise, a decade of progress Nat Clin Pract Oncol 4 2007 101 117
16. T. Shirakawa Clinical trial design for adenoviral gene therapy products Drug News Perspect 22 2009 140 145
17. S. Shukla, C. Dickmeis, A.S. Nagarajan, R. Fischer, U. Commandeur, and N.F. Steinmetz Molecular farming of fluorescent virus-based nanoparticles for optical imaging in plants, human cells and mouse models Biomater Sci 2 2014 784 797
18. K.L. Lee, K. Uhde-Holzem, R. Fischer, U. Commandeur, and N.F. Steinmetz Genetic engineering and chemical conjugation of potato virus X Methods Mol Biol 1108 2014 3 21
19. S. Shukla, A.L. Ablack, A.M. Wen, K.L. Lee, J.D. Lewis, and N.F. Steinmetz Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X Mol Pharm 10 2013 33 42
20. N.F. Steinmetz, C.F. Cho, A. Ablack, J.D. Lewis, and M. Manchester Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells Nanomedicine 6 2011 351 364
21. N.F. Steinmetz, A. Ablack, J.L. Hickey, J. Ablack, B. Manocha, and J.S. Mymryk Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing peptide receptors Small 7 2011 1664 1672
22. R.K. Huang, N.F. Steinmetz, C.Y. Fu, M. Manchester, and J.E. Johnson Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells Nanomedicine 6 2011 55 68
23. M.L. Hovlid, N.F. Steinmetz, B. Laufer, J.L. Lau, J. Kuzelka, and Q. Wang Guiding plant virus particles to integrin-displaying cells Nanoscale 4 2012 3698 3705
24. J.K. Pokorski, M.L. Hovlid, and M.G. Finn Cell targeting with hybrid qbeta virus-like particles displaying epidermal growth factor ChemBioChem 12 2011 2441 2447
25. S. Shukla, A.M. Wen, N.R. Ayat, U. Commandeur, R. Gopalkrishnan, and A.M. Broome Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice Nanomedicine 9 2014 221 235
26. J.M. Harris, and R.B. Chess Effect of pegylation on pharmaceuticals Nat Rev Drug Discov 2 2003 214 221
27. J.V. Jokerst, T. Lobovkina, R.N. Zare, and S.S. Gambhir Nanoparticle PEGylation for imaging and therapy Nanomedicine 6 2011 715 728
28. M.J. Roberts, M.D. Bentley, and J.M. Harris Chemistry for peptide and protein PEGylation Adv Drug Deliv Rev 54 2002 459 476
29. F.M. Veronese, and G. Pasut PEGylation, successful approach to drug delivery Drug Discov Today 10 2005 1451 1458
30. U. Wattendorf, and H.P. Merkle PEGylation as a tool for the biomedical engineering of surface modified microparticles J Pharm Sci 2008
31. S. Stoll, J. Delon, T.M. Brotz, and R.N. Germain Dynamic imaging of T cell-dendritic cell interactions in lymph nodes Science 296 2002 1873 1876
32. N.F. Steinmetz, M.E. Mertens, R.E. Taurog, J.E. Johnson, U. Commandeur, and R. Fischer Potato virus X as a novel platform for potential biomedical applications Nano Lett 10 2010 305 312
33. P.G. de Gennes Polymers at an interface: A simplified view Adv Colloid Interface Sci 27 1987 189 209
34. S. Shukla, A.L. Ablack, A.M. Wen, K.L. Lee, J.D. Lewis, and N.F. Steinmetz Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle potato virus X Mol Pharm 10 2013 33 42
35. R. Liu, R.A. Vaishnav, A.M. Roberts, and R.P. Friedland Humans have antibodies against a plant virus: Evidence from tobacco mosaic virus PLoS One 8 2013 e60621
36. J.A. Elliott, and W.C. Winn Jr. Treatment of alveolar macrophages with cytochalasin D inhibits uptake and subsequent growth of Legionella pneumophila Infect Immun 51 1986 31 36
37. O. Lunov, T. Syrovets, C. Loos, G.U. Nienhaus, V. Mailander, and K. Landfester Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages ACS Nano 5 2011 9648 9657
38. C.A. Vaine, M.K. Patel, J. Zhu, E. Lee, R.W. Finberg, and R.C. Hayward Tuning innate immune activation by surface texturing of polymer microparticles: The role of shape in inflammasome activation J Immunol 190 2013 3525 3532
39. A.S. Yazdi, G. Guarda, N. Riteau, S.K. Drexler, A. Tardivel, and I. Couillin Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta Proc Natl Acad Sci USA 107 2010 19449 19454
40. J.L. Perry, K.G. Reuter, M.P. Kai, K.P. Herlihy, S.W. Jones, and J.C. Luft PEGylated PRINT nanoparticles: The impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics Nano Lett 12 2012 5304 5310
41. J. Wolfram, Y. Yang, J. Shen, A. Moten, C. Chen, and H. Shen The nano-plasma interface: Implications of the protein corona Colloids Surf B 2014
42. M. Lundqvist Nanoparticles: Tracking protein corona over time Nat Nanotechnol 8 2013 701 702
43. S. Tenzer, D. Docter, J. Kuharev, A. Musyanovych, V. Fetz, and R. Hecht Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology Nat Nanotechnol 8 2013 772 781
44. D. Dell'Orco, M. Lundqvist, T. Cedervall, and S. Linse Delivery success rate of engineered nanoparticles in the presence of the protein corona: A systems-level screening Nanomedicine 8 2012 1271 1281
45. C. Gunawan, M. Lim, C.P. Marquis, and R. Amal Nanoparticle-protein corona complexes govern the biological fates and functions of nanoparticles J Mater Chem B 2 2014 2060 2083
46. D.E. Owens 3rd, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int J Pharm 307 2006 93 102
47. R. Michel, S. Pasche, M. Textor, and D.G. Castner Influence of PEG architecture on protein adsorption and conformation Langmuir 21 2005 12327 12332
48. A. Agrawal, and M. Manchester Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironments Biomacromolecules 13 2012 3320 3326
49. H. Mok, D.J. Palmer, P. Ng, and M.A. Barry Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses Mol Ther 11 2005 66 79
50. K. Nakano, Y. Bando, Y. Tozuka, and H. Takeuchi Cellular interaction of PEGylated PLGA nanospheres with macrophage J774 cells using flow cytometry Asian J Pharm Sci 2 2007 220 226
51. F. Ni, L. Jiang, R. Yang, Z. Chen, X. Qi, and J. Wang Effects of PEG length and iron oxide nanoparticles size on reduced protein adsorption and non-specific uptake by macrophage cells J Nanosci Nanotechnol 12 2012 2094 2100
52. Y. Sheng, Y. Yuan, C.S. Liu, X.Y. Tao, X.Q. Shan, and F. Xu In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: Effect of PEG content J Mater Sci Mater Med 20 2009 1881 1891
53. J. Xie, C. Xu, N. Kohler, Y. Hou, and S. Sun Controlled PEGylation of monodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cells Adv Mater 19 2007 3163
54. Q. Quan, J. Xie, H. Gao, M. Yang, F. Zhang, and G. Liu HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy Mol Pharm 8 2011 1669 1676
55. K. Kostarelos Carbon nanotubes: Fibrillar pharmacology Nat Mater 9 2010 793 795
56. A. Ruggiero, C.H. Villa, E. Bander, D.A. Rey, M. Bergkvist, and C.A. Batt Paradoxical glomerular filtration of carbon nanotubes Proc Natl Acad Sci USA 107 2010 12369 12374
57. R. Singh, D. Pantarotto, L. Lacerda, G. Pastorin, C. Klumpp, and M. Prato Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers Proc Natl Acad Sci USA 103 2006 3357 3362
58. M.A. Bruckman, L.N. Randolph, A. VanMeter, S. Hern, A.J. Shoffstall, and R.E. Taurog Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice Virology 449 2014 163 173
59. J.P. Almeida, A.Y. Lin, R.J. Langsner, P. Eckels, A.E. Foster, and R.A. Drezek In vivo immune cell distribution of gold nanoparticles in naive and tumor bearing mice Small 10 2014 812 819
60. M.E. Farkas, I.L. Aanei, C.R. Behrens, G.J. Tong, S.T. Murphy, and J.P. O'Neil PET Imaging and biodistribution of chemically modified bacteriophage MS2 Mol Pharm 10 2013 69 76
61. T.J. Molenaar, I. Michon, S.A. de Haas, T.J. van Berkel, J. Kuiper, and E.A. Biessen Uptake and processing of modified bacteriophage M13 in mice: Implications for phage display Virology 293 2002 182 191
62. D.E. Prasuhn Jr., P. Singh, E. Strable, S. Brown, M. Manchester, and M.G. Finn Plasma clearance of bacteriophage Qbeta particles as a function of surface charge J Am Chem Soc 130 2008 1328 1334
63. P. Singh, D. Prasuhn, R.M. Yeh, G. Destito, C.S. Rae, and K. Osborn Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo J Control Release 120 2007 41 50
64. C.R. Kaiser, M.L. Flenniken, E. Gillitzer, A.L. Harmsen, A.G. Harmsen, and M.A. Jutila Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo Int J Nanomed. 2 2007 715 733
65. Arnida, M.M. Janat-Amsbury, A. Ray, C.M. Peterson, and H. Ghandehari Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages Eur J Pharm Biopharm 77 2011 417 423
66. X.D. Zhang, D. Wu, X. Shen, P.X. Liu, N. Yang, and B. Zhao Size-dependent in vivo toxicity of PEG-coated gold nanoparticles Int J Nanomed 6 2011 2071 2081
67. A.K. Mohammad, and J.J. Reineke Quantitative detection of PLGA nanoparticle degradation in tissues following intravenous administration Mol Pharm 10 2013 2183 2189
68. E.J. Park, H.N. Umh, S.W. Kim, M.H. Cho, J.H. Kim, and Y. Kim ERK pathway is activated in bare-FeNPs-induced autophagy Arch Toxicol 88 2014 323 336
69. M. Bottini, N. Rosato, and N. Bottini PEG-modified carbon nanotubes in biomedicine: Current status and challenges ahead Biomacromolecules 12 2011 3381 3393
70. R.F. Hamilton Jr., Z. Wu, S. Mitra, P.K. Shaw, and A. Holian Effect of MWCNT size, carboxylation, and purification on in vitro and in vivo toxicity, inflammation and lung pathology Part Fibre Toxicol 10 2013 57
71. J.C. Kraft, J.P. Freeling, Z. Wang, and R.J. Ho Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems J Pharm Sci 103 2014 29 52
72. S. Lin, X. Wang, Z. Ji, C.H. Chang, Y. Dong, and H. Meng aspect ratio plays a role in the hazard potential of CeO nanoparticles in mouse lung and zebrafish gastrointestinal tract ACS Nano 2014
73. D.C. Baiu, C.S. Brazel, Y. Bao, and M. Otto Interactions of iron oxide nanoparticles with the immune system: Challenges and opportunities for their use in nano-oncology Curr Pharm Des 19 2013 6606 6621
74. J. Meng, M. Yang, F. Jia, Z. Xu, H. Kong, and H. Xu Immune responses of BALB/c mice to subcutaneously injected multi-walled carbon nanotubes Nanotoxicology 5 2011 583 591
75. K.S. Raja, Q. Wang, M.J. Gonzalez, M. Manchester, J.E. Johnson, and M.G. Finn Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus Biomacromolecules 4 2003 472 476
76. S.C. Semple, T.O. Harasym, K.A. Clow, S.M. Ansell, S.K. Klimuk, and M.J. Hope Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid J Pharmacol Exp Ther 312 2005 1020 1026
77. T. Shimizu, T. Ishida, and H. Kiwada Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon Immunobiology 218 2013 725 732
78. M.A. Croyle, N. Chirmule, Y. Zhang, and J.M. Wilson "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung J Virol 75 2001 4792 4801
79. G.K. Lee, N. Maheshri, B. Kaspar, and D.V. Schaffer PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization Biotechnol Bioeng 92 2005 24 34
80. C.R. O'Riordan, A. Lachapelle, C. Delgado, V. Parkes, S.C. Wadsworth, and A.E. Smith PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo Hum Gene Ther 10 1999 1349 1358
81. A. Wortmann, S. Vohringer, T. Engler, S. Corjon, R. Schirmbeck, and J. Reimann Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies Mol Ther 16 2008 154 162
82. B. De Geest, J. Snoeys, S. Van Linthout, J. Lievens, and D. Collen Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone Hum Gene Ther 16 2005 1439 1451
83. D.M. Brown, H. Johnston, E. Gubbins, and V. Stone Serum enhanced cytokine responses of macrophages to silica and iron oxide particles and nanomaterials: A comparison of serum to lung lining fluid and albumin dispersions J Appl Toxicol 2014
84. H.A. Khan, M.A. Abdelhalim, A.S. Alhomida, and M.S. Al Ayed Transient increase in IL-1beta, IL-6 and TNF-alpha gene expression in rat liver exposed to gold nanoparticles Genet Mol Res 12 2013 5851 5857
85. E. Meunier, A. Coste, D. Olagnier, H. Authier, L. Lefevre, and C. Dardenne Double-walled carbon nanotubes trigger IL-1beta release in human monocytes through Nlrp3 inflammasome activation Nanomedicine 8 2012 987 995
86. K. Maruyama, T. Yuda, A. Okamoto, S. Kojima, A. Suginaka, and M. Iwatsuru Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol) Biochim Biophys Acta 1128 1992 44 49
87. Q. Yang, S.W. Jones, C.L. Parker, W.C. Zamboni, J.E. Bear, and S.K. Lai Evading Immune Cell Uptake and Clearance Requires PEG Grafting at Densities Substantially Exceeding the Minimum for Brush Conformation Mol Pharm 2014
88. J. Fang, H. Nakamura, and H. Maeda The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv Drug Deliv Rev 63 2011 136 151
89. M.S. Murahari, and M.C. Yergeri Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer Curr Pharm Des 19 2013 4622 4640
90. D.E. Sosnovik, M. Nahrendorf, and R. Weissleder Magnetic nanoparticles for MR imaging: Agents, techniques and cardiovascular applications Basic Res Cardiol 103 2008 122 130
91. J.K. Pokorski, K. Breitenkamp, L.O. Liepold, S. Qazi, and M.G. Finn Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization J Am Chem Soc 133 2011 9242 9245